|
|
Found results for
patents
1.
|
PHARMACEUTICAL PRODUCT FOR TREATING LUPUS ERYTHEMATOSUS AND COMBINED IMMUNE DEFECT, AND PREPARATION AND APPLICATION THEREOF
| Application Number |
CN2016078649 |
| Publication Number |
2017/173609 |
| Status |
In Force |
| Filing Date |
2016-04-07 |
| Publication Date |
2017-10-12 |
| Owner |
BEIJING LU DE KAI QI CO., LTD. (China)
|
| Inventor |
Lu, Wei
|
Abstract
A pharmaceutical product for treating lupus erythematosus and for enhancing immunity. The product comprises the following raw materials (in parts by weight): a Juglans regia extract (1), Blumea balsamifera extract (0.5-2), Panax quinquefolius extract (1-5), and Dendrobium nobile extract (1-10). The pharmaceutical product is prepared using a supercritical fluid extraction process and a spray drying process. The pharmaceutical product can enhance immunity and can prevent or treat lupus erythematosus.
|
2.
|
PHARMACEUTICAL PRODUCT FOR TREATING ANKYLOSING SPONDYLITIS AND COMBINED IMMUNE DEFECT, AND PREPARATION AND APPLICATION THEREOF
| Application Number |
CN2016078650 |
| Publication Number |
2017/173610 |
| Status |
In Force |
| Filing Date |
2016-04-07 |
| Publication Date |
2017-10-12 |
| Owner |
BEIJING LU DE KAI QI CO., LTD. (China)
|
| Inventor |
Lu, Wei
|
Abstract
A pharmaceutical product for treating ankylosing spondylitis and combined immune defect. Raw materials of the pharmaceutical product comprises a Rosa roxbunghii extract, a Blumea balsamifera extract, a seahorse extract, and a Corydalis yanhusuo extract respectively provided in a weight ratio of (1-10):(0.5-2):1:(1-10). The pharmaceutical product is prepared using a supercritical fluid extraction process, facilitating in vivo dissolution and human body absorption.
IPC Classes ?
- A61K 36/738 - Rosa (rose)
- A61K 36/66 - Papaveraceae (Poppy family), e.g. bloodroot
- A61K 36/282 - Artemisia, e.g. wormwood or sagebrush
- A61K 35/60 - Fish, e.g. seahorsesFish eggs
- A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
- A61P 19/08 - Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P 37/04 - Immunostimulants
|
3.
|
PHARMACEUTICAL PRODUCT FOR TREATING TUMOR AND COMBINED IMMUNE DEFECT, AND PREPARATION AND APPLICATION THEREOF
| Application Number |
CN2016078651 |
| Publication Number |
2017/173611 |
| Status |
In Force |
| Filing Date |
2016-04-07 |
| Publication Date |
2017-10-12 |
| Owner |
BEIJING LU DE KAI QI CO., LTD. (China)
|
| Inventor |
Lu, Wei
|
Abstract
A pharmaceutical composition for treating a tumor and combined immune defect. The composition comprises a Juglans regia extract, a Blumea balsamifera extract, and a Syzygium aromaticum extract provided in a weight ratio of 77:54:98. The composition can suppress microbial growth and exerts anti-microbial effects, enhance the immunity of an organism, provides stronger anticancer activity, and can prevent tumor recurrence. The composition is prepared using a supercritical fluid extraction process.
IPC Classes ?
- A61K 36/61 - Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
- A61K 36/52 - Juglandaceae (Walnut family)
- A61K 36/282 - Artemisia, e.g. wormwood or sagebrush
- A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
- A61P 35/00 - Antineoplastic agents
|
|